ECTRIMS Meeting in Montreal
New advances were presented at an international multiple sclerosis meeting(ECTRIMS/ACTRIMS/LACTRIMS) on September 17-20, 2008.
New advances were presented at an international multiple sclerosis meeting(ECTRIMS/ACTRIMS/LACTRIMS) on September 17-20, 2008.
The US Food and Drug Administration have granted a “fast track” review of dirucotide (MBP8298) for the treatment of secondary progressive disease.